"This historic time of crisis demanded bold action at every level of Colorado State University," says the narrator of CSU's latest video: "Action in a Time of Crisis: Colorado State University Research Retrospective."
Anna Fagre, a veterinarian and postdoctoral fellow at Colorado State University who collaborates with Carlson’s project, proposes that we start by developing comprehensive measures for what a healthy wildlife population looks like.
A little over a year ago, Goodrich and several other scientists at Colorado State University dropped what they were doing and devoted their full attention to developing coronavirus vaccines, hoping to end what was then a very young pandemic.
Dr. Heather Pidcoke, chief medical research officer, battled follicular lymphoma during the coronavirus pandemic.
Join the 'Action in the Time of Crisis' watch party for a recap of the work researchers have accomplished over the past year.
When Colorado Gov. Jared Polis announced on Feb. 26 that student-facing faculty and staff at colleges and universities would be added to the phased rollout of the COVID-19 vaccines as early as March 21, many of the state's higher education employees breathed a sigh of relief.
CSU will host a town hall session for the university community on Friday, March 12, to provide updates and answer questions about its ongoing response to the COVID pandemic.
Early in the pandemic, a CSU team set out to quantify the dynamics of how aerosols like viruses travel from one person to another, under different circumstances.
Sometimes, symptoms of a disease are obvious – think of the mass mortality events observed in crows infected with West Nile Virus (a mosquito-borne virus that can also cause febrile illness in humans), says Angela Bosco-Lauth, a virologist and veterinarian and at Colorado State University. Often, signs are much subtler – if they are there at all.
Researchers aim to create a vaccine candidate that would protect people from a spectrum of coronaviruses.